Interleukin-2 (IL-2), Interleukin-5 (IL-5) and Interleukin-17 (IL-17) Levels of Patients With Stainless Steel Crowns

计划入组 12 人 · 首次发布于 2024 年 6 月 3 日

Anti-IL-17 a New Treatment for Contact Dermatititis

计划入组 20 人 · 首次发布于 2016 年 5 月 20 日

IL-17 Blockade to Decrease irAEs (REPLAY)

计划入组 4 人 · 首次发布于 2025 年 11 月 20 日

IL-17 NanoAb

A-17

IL-17 vaccine

Arvinas Estrogen Receptor, Inc.

United States

Simcha Il 18, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Seven-Year US Safety Data Confirms Brodalumab's Stable Risk Profile in Psoriasis Treatment

FDA Clears Ascletis' IND for ASC50, a Novel Oral IL-17 Inhibitor for Psoriasis Treatment

IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients